IJMS | Free Full-Text | BRAF Gene and Melanoma: Back to the Future | HTML
Pharmaceuticals | Free Full-Text | Hacking Pancreatic Cancer: Present and Future of Personalized Medicine | HTML
Adevăratele motive ale impozitării progresive, dezvăluite de trei experți financiari. Pe cine va afecta aplicarea măsurii
Stat Consult: Endometriosis - Clinical Advisor
Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development | Journal of Medicinal Chemistry
Dynamic Bayesian networks for prediction of health status and treatment effect in patients with chronic lymphocytic leukemia | Scientific Reports
Cota unica sau impozitare progresiva: ce e mai bine pentru romani?
Genetic and Neuroendocrine Regulation of Human Growth (Chapter 6) - Patterns of Human Growth
Cota unică vs impozitarea progresivă. Gabriel Biriș: Suntem în aceeași situație ca acum 16 ani, doar cu deficite mult amplificate. Și o întrebare pentru Marcel Ciolacu: „Vrea cote progresive pe toate veniturile,
Pickering Emulsifiers Based on Block Copolymer Nanoparticles Prepared by Polymerization-Induced Self-Assembly | Langmuir
Signaling Pathways and Targeted Therapies for Stem Cells in Prostate Cancer | ACS Pharmacology & Translational Science
Signa Vitae-Journal of Anesthesiology, Intensive Care Journal, Emergency Medical Journal
Revenirea la impozitul progresiv: avantaje şi dezavantaje. Cu cât ar strânge mai mult statul?
3. How does inequality shape the demand for redistribution? | Does Inequality Matter? : How People Perceive Economic Disparities and Social Mobility | OECD iLibrary